# Immunogenicity and Safety of Adacel Polio Vaccine

> **NCT00797511** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 132 (actual)

## Conditions studied

- Diphtheria
- Tetanus
- Pertussis
- Poliomyelitis

## Interventions

- **BIOLOGICAL:** TdcP-IPV vaccine

## Key facts

- **NCT ID:** NCT00797511
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-07
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2012-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00797511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00797511, "Immunogenicity and Safety of Adacel Polio Vaccine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00797511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*